JP Morgan Chase
DPLO

JP Morgan Chase’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

JP Morgan Chase’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-490,000
Closed -$6.59M – 6186
2018
Q4 		$6.59M Buy
490,000
+350,000
+250% +$5.9M ﹤0.01% 2350
2018
Q3 		$2.72M Buy
+140,000
New +$2.98M ﹤0.01% 3241

Other funds holding DPLO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

JP Morgan Chase's DPLO Position: Q1 2020 in Review

JP Morgan Chase sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 1,077,089 shares — an estimated $4.31M sold.

JP Morgan Chase first reported a position in DPLO in Q4 2014 and held it in 20 quarters. The position peaked at $20.5M in Q4 2017. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • JP Morgan Chase reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • JP Morgan Chase sold 1,077,089 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $4.31M.
  • JP Morgan Chase first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 20 quarters.
  • JP Morgan Chase's DIPLOMAT PHARMACY, INC. position peaked at $20.5M in Q4 2017.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.